Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality

被引：153

作者：

Miksad, Rebecca A. ^{[1
]}

Abernethy, Amy P. ^{[1
]}

机构：

[1] Flatiron Hlth Inc, New York, NY 10010 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷 / 02期

关键词：

D O I：

10.1002/cpt.946

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The role of real-world evidence (RWE) in regulatory, drug development, and healthcare decision-making is rapidly expanding. Recent advances have increased the complexity of cancer care and widened the gap between randomized clinical trial (RCT) results and the evidence needed for real-world clinical decisions. Instead of remaining invisible, data from the >95% of cancer patients treated outside of clinical trials can help fill this void.

引用

页码：202 / 205

页数：4

共 5 条

[1] Opportunities and challenges in leveraging electronic health record data in oncology [J].